بدائل البحث:
largest decrease » marked decrease (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
largest decrease » marked decrease (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
-
621
Fig 29 in each curve fitting results.
منشور في 2024"…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …"
-
622
Fig 9(b) in the straight-line fitting results.
منشور في 2024"…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …"
-
623
Specimen packaging process.
منشور في 2024"…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …"
-
624
Relationship between τ<sub><i>i</i></sub> and σ<sub><i>i</i></sub>.
منشور في 2024"…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …"
-
625
The relationship between Δσ<sub>n</sub> and τ<sub>1</sub>, <i>JRC</i>.
منشور في 2024"…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …"
-
626
Relationship between τ<sub><i>i</i></sub> and σ<sub><i>i</i></sub>.
منشور في 2024"…Under the same <i>JRC</i>, σ<sub><i>i</i></sub> increases with the increase of τ<sub>1</sub>, and Δσ<sub>n</sub> decreases with the increasing τ<sub>1</sub>. Under the same <i>JRC</i> and σ<sub><i>i</i></sub>, τ<sub><i>i</i></sub> is significantly smaller under the UNLCSL path than the CNL path. …"
-
627
-
628
-
629
-
630
Flowchart of the screening process.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
631
Result of the AMSTAR-2 assessments.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
632
Characteristics of included reviews.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
633
Result of the PRISMA assessments.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
634
Result of the ROBIS assessments.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
635
-
636
-
637
-
638
-
639
-
640